Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Tables)

v3.24.1.1.u2
SHARE BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
SHARE-BASED COMPENSATION  
Summary of components of share-based compensation expense

    

Three-Month Periods Ended March 31,

($’s in thousands)

    

2024

    

2023

Research and development

$

145

$

33

Selling, general and administrative

 

1,261

 

613

Total non-cash compensation expense related to share-based compensation included in operating expense

$

1,406

$

646

Schedule of stock option activities

Weighted

    

    

Weighted

    

    

average

Number

average

Aggregate

remaining

of

exercise

intrinsic

contractual 

    

Shares

    

price

    

value

    

life (years)

Outstanding options at December 31, 2023

2,769,869

$

1.49

$

6,053,833

4.53

Granted

25,000

4.57

Exercised

(55,375)

1.22

Forfeited

(65,523)

2.91

Expired

(1,250)

2.62

Outstanding options at March 31, 2024

 

2,672,721

$

1.49

$

5,866,003

 

4.23

Options vested and exercisable at March 31, 2024

 

1,991,507

$

0.97

$

5,393,973

 

2.73

Schedule of restricted stock units

    

Weighted

Number of

average grant

    

units

    

date Fair value

Unvested balance at December 31, 2023

 

1,306,923

$

3.88

Granted

 

887,500

 

4.97

Vested

(211,028)

3.58

Forfeited

(10,000)

5.02

Unvested balance at March 31, 2024

1,973,395

$

4.40